Literature DB >> 7482663

Widespread appearance of Alz-50 immunoreactive neurons in the human brain with cerebral infarction.

T Uchihara1, K Tsuchiya, H Kondo, T Hayama, K Ikeda.   

Abstract

BACKGROUND AND
PURPOSE: Tau-like immunoreactivity is known to develop in neurons under some experimental conditions simulating ischemia. The purpose of this study is to investigate the expression of tau-like immunoreactivity in the human brain after ischemic insult.
METHODS: A series of autopsied human brains with or without ischemic lesion were investigated with immunohistochemistry (Alz-50, anti-tau, and anti-ubiquitin) and with silver-staining methods (Gallyas and Bodian methods).
RESULTS: Punctate immunoreactivity to Alz-50 was visualized in the cytoplasm not only of the neurons in and around the ischemic lesion but also of the neurons free from classic ischemic changes around the necrosis. Some of the neurons around the ischemic lesion were stained by the Gallyas method. Immunostaining with anti-tau and anti-ubiquitin antibodies and the conventional Bodian method failed to visualize these neurons.
CONCLUSIONS: The widespread appearance of Alz-50 immunoreactive neurons during the ischemic process signifies that tau-related proteins may be related to ischemic necrosis, but the lack of neurofibrillary tangles morphologically distinguishes ischemic development of tau-related proteins from the neurofibrillary degeneration in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7482663     DOI: 10.1161/01.str.26.11.2145

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Elevated 18F-AV-1451 PET tracer uptake detected in incidental imaging findings.

Authors:  Samuel N Lockhart; Nagehan Ayakta; Joseph R Winer; Renaud La Joie; Gil D Rabinovici; William J Jagust
Journal:  Neurology       Date:  2017-02-10       Impact factor: 9.910

Review 2.  The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer's Disease Type.

Authors:  Ryszard Pluta; Stanisław J Czuczwar; Sławomir Januszewski; Mirosław Jabłoński
Journal:  Cells       Date:  2021-08-27       Impact factor: 7.666

3.  Physiologic Reelin does not play a strong role in protection against acute stroke.

Authors:  Courtney Lane-Donovan; Charisma Desai; Theresa Pohlkamp; Erik J Plautz; Joachim Herz; Ann M Stowe
Journal:  J Cereb Blood Flow Metab       Date:  2016-05-04       Impact factor: 6.200

Review 4.  Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.

Authors:  Gloria Patricia Cardona-Gómez; Francisco Lopera
Journal:  Front Aging Neurosci       Date:  2016-12-20       Impact factor: 5.750

Review 5.  Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.

Authors:  Marzena Ułamek-Kozioł; Stanisław Jerzy Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

6.  Acetylated Tau Protein: A New Piece in the Puzzle between Brain Ischemia and Alzheimer's Disease.

Authors:  Ryszard Pluta; Sławomir Januszewski; Mirosław Jabłoński
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

7.  Multimodal 18F-AV-1451 and MRI Findings in Nonfluent Variant of Primary Progressive Aphasia: Possible Insights on Nodal Propagation of Tau Protein Across the Syntactic Network.

Authors:  Belen Pascual; Quentin Funk; Paolo Zanotti-Fregonara; Neha Pal; Elijah Rockers; Meixiang Yu; Bryan Spann; Gustavo C Román; Paul E Schulz; Christof Karmonik; Stanley H Appel; Joseph C Masdeu
Journal:  J Nucl Med       Date:  2019-07-26       Impact factor: 10.057

Review 8.  Tau Protein Dysfunction after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 9.  Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer's Disease to Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.